Navigation Links
Positive Clinical Results for DG041 Lead Product Development,Highlights at deCODE R&D Event

Recent clinical studies support the development of DG041 as an effective anti-platelet that does not increase bleeding risk

REYKJAVIK, Iceland, June 25, 2007 /PRNewswire-FirstCall/ -- deCODE genetics today announced progress in the development of DG041, the company's Phase II developmental compound for the prevention of arterial thrombosis. The results of the Phase IIa and clinical pharmacology studies presented today build upon previous findings demonstrating DG041's profile as an anti-platelet compound that deCODE expects will make it possible to block the formation of blood clots mediated through inflammation in atherosclerotic plaques but without increasing bleeding risk. There is a large unmet medical need for a drug with these characteristics, with applicability to the prevention of heart attack, stroke and the progression of peripheral artery disease (PAD). Drugs such as Plavix(TM) and aspirin, the current mainstays of oral anti-platelet therapy, significantly increase the risk of bleeding by broadly blocking platelet activity.

Recent advances in deCODE's therapeutic and diagnostics pipeline will be discussed at the company's annual R&D event being held today in Reykjavik. The presentations will be webcast live through the investors page of the company's website at http://www.decode.com, starting at 9am GMT/5am EDT, and will be archived on the site. Among the highlights to be discussed are:

DG041 -- Arterial thrombosis.

DG041 is a novel, first in class antagonist of the EP3 receptor for prostaglandins E2. deCODE initially identified EP3 as a target by isolating variants in the gene encoding the EP3 receptor for prostaglandins E2 (PGE2) that approximately double the risk of PAD, a common and debilitating atherosclerotic condition in which the flow of blood to the legs is progressively constricted. The mechanism through which EP3
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
(Date:8/27/2014)... Reportlinker.com announces that a new market ... Global Heart Valve Repair and Replacement Market ... About Heart Valve Repair and Replacement Heart ... control the flow of blood during the cardiac ... such as valvular stenosis, valvular insufficiency or regurgitation, ...
(Date:8/27/2014)... 2014 Reportlinker.com announces that a new ... Global Animal Health Market 2014-2018 ... Animal Health Animal health refers to veterinary services ... to enhance their quality of life, increase their ... The Global Animal Health market covers the following ...
(Date:8/27/2014)... 2014 Kewaunee Scientific Corporation (Nasdaq: ... its quarterly cash dividend by 9% to twelve cents ... beginning with the dividend payable on September 22, 2014 ... on September 8, 2014. About Kewaunee ... Scientific Corporation is a recognized global leader in the ...
Breaking Medicine Technology:Global Heart Valve Repair and Replacement Market 2014-2018 2Global Heart Valve Repair and Replacement Market 2014-2018 3Global Heart Valve Repair and Replacement Market 2014-2018 4Global Animal Health Market 2014-2018 2Global Animal Health Market 2014-2018 3Global Animal Health Market 2014-2018 4Global Animal Health Market 2014-2018 5Global Animal Health Market 2014-2018 6Global Animal Health Market 2014-2018 7
... Researchers discover that proteins BMP2, BMP4 and BMP7 ... cells to develop,into normal neurons, a finding that ... MEMPHIS, Tenn., March 14 A discovery by ... way to treat,medulloblastoma, a rare but often fatal ...
... Alliance,(LCA) called the new screening guidelines announced by the ... right direction,that will encourage those at high risk for ... CT scan.", LCA President Laurie Fenton Ambrose said ... year than all the other major cancers combined,until more ...
Cached Medicine Technology:St. Jude Finds Signaling System That Halts the Growth of a Childhood Brain Cancer 2Lung Cancer Alliance Commends NCCN on Screening Guidelines 2
(Date:8/27/2014)... HealthDay Reporter , TUESDAY, Aug. 26, 2014 ... of new heart disease treatments are generally younger and healthier ... Experts said the findings, which appear in the Aug. 27 ... -- but they are troubling. "It,s of major concern ... that is not fully representative of the real-world patients encountered ...
(Date:8/27/2014)... LEBANON, NH Recent growth in health care spending ... in prices for medical services, rather than increased use, ... The Dartmouth Institute for Health Policy & Clinical Practice, ... Journal of Managed Care . , There is increasing ... lead to increased prices faced by payers and, ultimately, ...
(Date:8/27/2014)... LA JOLLA, CA August 27, 2014 Scientists ... mystery of why a specific signaling pathway can be ... is regulated by a gene, called neurofibromatosis type 1 ... drinking in mice. The new research shows Nf1 regulates ... increases feelings of relaxation. , "This novel and ...
(Date:8/27/2014)... August 27, 2014 Dr. Winifred S. ... a leader in promoting better health outcomes through the ... of Ms. Maura Connor to the executive team effective ... Ms. Connor will be responsible for providing innovation, leadership, ... products and content across all markets. , “Maura ...
(Date:8/27/2014)... attention, mom and dad, especially when your infant looks ... a baby,s prattling, but by listening and responding, they ... to children forming complex sounds and using language more ... the University of Iowa and Indiana University that found ... shape the way infants communicate and use vocalizations. , ...
Breaking Medicine News(10 mins):Health News:Heart Studies Don't Reflect Real-World Patients, Study Finds 2Health News:Heart Studies Don't Reflect Real-World Patients, Study Finds 3Health News:Tracking spending among the commercially insured 2Health News:Scripps Research Institute scientists link alcohol-dependence gene to neurotransmitter 2Health News:Maura Connor Joins Hayes, Inc. as Vice President, Digital Publishing, Editor-in-Chief 2Health News:Parents, listen next time your baby babbles 2Health News:Parents, listen next time your baby babbles 3
... awarded a Phase II Early Career Award from the Wallace ... a device that uses light to detect skin cancer without ... grant will support Tunnell,s work for the next two years ... conduct additional clinical trials. He previously received one of 23 ...
... Shows Alarming Trends in Cosmetic Surgery and Health Risks ... ... YWCA USA today released a new,report that reveals the impact of ... and interpersonal,relationships of American women and girls. The report, Beauty at ...
... SHELTON, Conn., Aug. 18 Enhanced Care,Initiatives (ECI ... today,announced that it has signed a two year ... support the transformation of primary care practices into,Medical ... Medical Home,Project, which seeks to promote improved care ...
... could be key, researchers say , , MONDAY, Aug. 18 (HealthDay ... up with an unruly head of hair from time to ... find out why it misbehaves -- and how to tame ... first of its kind, German researchers say they,ve gotten extreme-close-up ...
... Medical,Association (AMA) Foundation awarded the Arthur N. Wilson, ... up in Sitka, Alaska and attends,the University of ... scholarship to help defray medical school expenses. The ... student who graduated,from a high school in southeast ...
... INDIANAPOLIS, Aug. 18 Over 900,employees and families of ... one of the Wyndham Worldwide family of brands (NYSE: ... RCI co-founder Christel DeHaan and,many of her former RCI ... Carmel-area campus of the world,s largest timeshare exchange,company to ...
Cached Medicine News:Health News:New probe to detect skin cancer receives more funding for clinical trials 2Health News:America's Beauty Obsession Poses Serious Consequences for Women and Girls, Report Reveals 2Health News:Enhanced Care Initiatives (HC Innovations, Inc.) Contracts with HIP and GHI to Create a Medical Home Network Project with Support from the Commonwealth Fund 2Health News:Enhanced Care Initiatives (HC Innovations, Inc.) Contracts with HIP and GHI to Create a Medical Home Network Project with Support from the Commonwealth Fund 3Health News:Enhanced Care Initiatives (HC Innovations, Inc.) Contracts with HIP and GHI to Create a Medical Home Network Project with Support from the Commonwealth Fund 4Health News:Science May Banish Bad Hair Days 2Health News:AMA Foundation Presents the Arthur N. Wilson, MD Scholarship to Promising Medical Student From Southeast Alaska 2Health News:Group RCI Gifts $100,000 to Christel House International Founder at Company Block Party 2Health News:Group RCI Gifts $100,000 to Christel House International Founder at Company Block Party 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: